M. Jöris

Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology Group

F. Claas, R. Egeler, M. Oudshoorn, 2012, Bone Marrow Transplantation.

Impact of COVID-19 pandemic on global unrelated stem cell donations in 2020—Report from World Marrow Donor Association

B. Shaw, S. Devine, S. Forman, 2021, Bone Marrow Transplantation.

A Proposed Algorithm Predictive for Cytotoxic T Cell Alloreactivity

D. Roelen, F. Claas, M. Oudshoorn, 2012, The Journal of Immunology.

Translating in vitro prediction of cytotoxic T cell alloreactivity to hematopoietic stem cell transplantation outcome.

F. Claas, B. van der Holt, P. A. von dem Borne, 2014, Transplant immunology.

Physiochemical disparity of mismatched HLA class I alloantigens and risk of acute GVHD following HSCT

D. Mallon, J. Bradley, M. Oudshoorn, 2015, Bone Marrow Transplantation.

The impact of frequent HLA haplotypes in high linkage disequilibrium on donor search and clinical outcome after unrelated haematopoietic SCT

F. Claas, M. Oudshoorn, J. Kuball, 2013, Bone Marrow Transplantation.

Worldwide survey on key indicators for public cord blood banking technologies: By the World Marrow Donor Association Cord Blood Working Group

S. Gómez, S. Querol, E. Baudoux, 2020, Stem cells translational medicine.